141998-77-8 Usage
Uses
Used in Organic Synthesis:
Ethyl 5-iodo-1H-pyrazole-3-carboxylate is utilized as a synthetic intermediate for the preparation of a variety of organic compounds. Its presence of functional groups facilitates multiple reaction pathways, making it a versatile component in the construction of complex organic molecules.
Used in Pharmaceutical Research:
In the pharmaceutical industry, Ethyl 5-iodo-1H-pyrazole-3-carboxylate is employed as a building block for the synthesis of bioactive molecules and pharmaceutical compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Chemical Reaction Studies:
Ethyl 5-iodo-1H-pyrazole-3-carboxylate is used as a reagent in studying chemical reactions. Its reactivity with different chemical entities provides insights into reaction mechanisms and helps in the development of new synthetic methods.
Used in Agricultural Chemical Development:
Ethyl 5-iodo-1H-pyrazole-3-carboxylate may be used as a precursor in the development of agricultural chemicals. Its potential role in creating new pesticides or other agrochemicals could contribute to more effective and sustainable agricultural practices.
Used in Materials Science:
In the field of materials science, Ethyl 5-iodo-1H-pyrazole-3-carboxylate could be utilized in the synthesis of new materials with specific properties. Its structural features may contribute to the development of advanced materials for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 141998-77-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,1,9,9 and 8 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 141998-77:
(8*1)+(7*4)+(6*1)+(5*9)+(4*9)+(3*8)+(2*7)+(1*7)=168
168 % 10 = 8
So 141998-77-8 is a valid CAS Registry Number.
141998-77-8Relevant academic research and scientific papers
PYRAZOLO[1,5-D][1,2,4]TRIAZINE-5(4H)-ACETAMIDES AS INHIBITORS OF THE NLRP3 INFLAMMASOME PATHWAY
-
Page/Page column 58, (2021/10/22)
The invention relates to novel compounds for use as inhibitors of NLRP3 inflammasone production, wherein such compounds are as defined by compounds of formula (I) and wherein the integers R1, R2 and R3 are defined in the description, and where the compounds may be useful as medicaments, for instance for use in the treatment of a disease or disorder that is associated with NLRP3 inflammasome activity.
POLYCYCLIC AMIDES AS UBE2K MODULATORS FOR TREATING CANCER
-
Paragraph 0061; 0062-0066, (2021/07/10)
Provided are compounds of Formula (I) and pharmaceutically acceptable salts and compositions thereof, which are useful for treating conditions associated with modulation of UBE2K.
HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS
-
Page/Page column 207, (2021/08/20)
Heteroaromatic carboxamides of formula (I), wherein Y, R, and Ar are as defined in the description and the claims, and pharmaceutically acceptable salts thereof can be used in methods for the treatment of diseases which can be influenced by the inhibition of plasma kallikrein.
